Tag: Pharma Regulations

Pharma – Asia, S America, MENA, ROW Regulatory News – March 2025

April 15, 2025
Biopharma

ARGENTINA ANMAT in numbers: Advertising Monitoring and Inspection Program The Program for Monitoring and Oversight of Advertising and Promotion of Products Subject to Health Surveillance is...

Drug Approvals, Drug Safety, Global Health, Healthcare Policy, Medical Regulations, Pharma Compliance, Pharma Industry, Pharma Regulations, Pharma Updates, Regulatory News

Pharma/Biotech – USA, Europe, Asia and ROW Regulatory News – Feb 2025

March 11, 2025
Biopharma

USA FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes The U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog...

Asia Biotech, Biotech 2025, Biotech Insights, Biotech Updates, Europe Pharma, Pharma News, Pharma Regulations, Pharma Trends, Regulatory Affairs, ROW Regulatory, USA Regulations

2024 Recap: Consumer Health key Regulation/Guidance in USA, EU, Asia and ROW

December 17, 2024
Consumer Health

USA EUROPE ARGENTINA AUSTRALIA BRAZIL CHINA ISRAEL MALAYSIA PHILIPPINES SINGAPORE SWITZERLAND ul.countries { display:flex; list-style:...

Asia, Compliance, Consumer Health, Consumer Safety, EU, Global Health, Global Trends, Guidance, Health Compliance, Health Innovation, Health Policy, Health Standards., Health Updates, Healthcare Regulations, Medical Regulations, Pharma Regulations, Regulations, Regulatory Compliance, Regulatory Updates, ROW, USA

Pharma/Biotech – USA, Europe, Asia and ROW Regulatory News – Feb. 2024

March 7, 2024
Biopharma

USA FDA Modernizes Informed Consent Guidance, Aligning With Common Rule Changes The FDA has published new draft guidance on informed consent that lines up with revisions to the Common Rule made...

Asia Biotech News, Asia Regulations, Biotech News, DSCSA Compliance, EU Regulatory, FDA Updates, Global Healthcare, Pharma Regulations, Singapore Healthcare, Swiss Medic